Do analysts prefer UFPT or BLCO?

Bausch + Lomb has a consensus target price of $20.83, indicating a potential upside of 4.27%. Given Bausch + Lomb's stronger consensus rating and higher probable upside, analysts plainly believe Bausch + Lomb is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Bausch + Lomb 1 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.47

Does the media favor UFPT or BLCO?

In the previous week, Bausch + Lomb had 6 more articles in the media than UFP Technologies. MarketBeat recorded 24 mentions for Bausch + Lomb and 18 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 0.74 beat Bausch + Lomb's score of 0.62 indicating that UFP Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 6 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bausch + Lomb 6 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend UFPT or MMSI?

Merit Medical Systems has a consensus target price of $105.55, indicating a potential upside of 21.00%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Merit Medical Systems 0 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.62

Does the media favor UFPT or MMSI?

In the previous week, UFP Technologies had 7 more articles in the media than Merit Medical Systems. MarketBeat recorded 18 mentions for UFP Technologies and 11 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.84 beat UFP Technologies' score of 0.74 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 6 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 4 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer UFPT or ICUI?

ICU Medical has a consensus price target of $195.20, indicating a potential upside of 13.42%. Given ICU Medical's stronger consensus rating and higher possible upside, analysts plainly believe ICU Medical is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 ICU Medical 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.89

Does the media refer more to UFPT or ICUI?

In the previous week, ICU Medical had 2 more articles in the media than UFP Technologies. MarketBeat recorded 20 mentions for ICU Medical and 18 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 0.74 beat ICU Medical's score of 0.62 indicating that UFP Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 6 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ICU Medical 4 Very Positive mention(s) 2 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend UFPT or NVST?

Envista has a consensus target price of $29.00, indicating a potential upside of 15.09%. Given Envista's stronger consensus rating and higher probable upside, analysts plainly believe Envista is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Envista 0 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.35

Is UFPT or NVST more profitable?

Envista has a net margin of 22.01% compared to UFP Technologies' net margin of 11.78%. UFP Technologies' return on equity of 18.46% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets UFP Technologies 11.78% 18.46% 12.41% Envista 22.01% 8.26% 4.54%

Does the media favor UFPT or NVST?

In the previous week, Envista had 1 more articles in the media than UFP Technologies. MarketBeat recorded 19 mentions for Envista and 18 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 0.74 beat Envista's score of 0.56 indicating that UFP Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 6 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 3 Very Positive mention(s) 5 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend UFPT or NEOG?

Neogen has a consensus target price of $12.67, suggesting a potential upside of 7.71%. Given Neogen's stronger consensus rating and higher possible upside, analysts clearly believe Neogen is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Neogen 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Is UFPT or NEOG more profitable?

UFP Technologies has a net margin of 11.78% compared to Neogen's net margin of -6.35%. UFP Technologies' return on equity of 18.46% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets UFP Technologies 11.78% 18.46% 12.41% Neogen -6.35% 3.29% 2.06%

Does the media favor UFPT or NEOG?

In the previous week, UFP Technologies had 7 more articles in the media than Neogen. MarketBeat recorded 18 mentions for UFP Technologies and 11 mentions for Neogen. UFP Technologies' average media sentiment score of 0.74 beat Neogen's score of 0.53 indicating that UFP Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 6 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neogen 4 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

UFP Technologies (UFPT) Competitors

$303.47 +3.65 (+1.22%)

Closing price 11/6/2026 04:00 PM Eastern

Extended Trading

$303.10 -0.37 (-0.12%)

As of 11/6/2026 07:30 PM Eastern

Compare

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

Should you buy UFP Technologies stock or one of its competitors? UFP Technologies's main competitors and comparable companies include Bausch + Lomb (BLCO), Merit Medical Systems (MMSI), ICU Medical (ICUI), Envista (NVST), and Neogen (NEOG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does UFP Technologies compare to Bausch + Lomb?

UFP Technologies (NASDAQ:UFPT) and Bausch + Lomb (NYSE:BLCO) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, Bausch + Lomb had 6 more articles in the media than UFP Technologies. MarketBeat recorded 24 mentions for Bausch + Lomb and 18 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 0.74 beat Bausch + Lomb's score of 0.62 indicating that UFP Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	6 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bausch + Lomb	6 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

UFP Technologies has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.90	$68.31M	$9.81	30.93
Bausch + Lomb	$5.10B	1.40	-$360M	-$0.31	N/A

UFP Technologies has a net margin of 11.78% compared to Bausch + Lomb's net margin of -2.05%. UFP Technologies' return on equity of 18.46% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.78%	18.46%	12.41%
Bausch + Lomb	-2.05%	5.01%	2.34%

UFP Technologies has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market.

87.3% of UFP Technologies shares are owned by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are owned by institutional investors. 4.6% of UFP Technologies shares are owned by insiders. Comparatively, 1.5% of Bausch + Lomb shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Bausch + Lomb has a consensus target price of $20.83, indicating a potential upside of 4.27%. Given Bausch + Lomb's stronger consensus rating and higher probable upside, analysts plainly believe Bausch + Lomb is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bausch + Lomb	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.47

Summary

UFP Technologies beats Bausch + Lomb on 11 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to Merit Medical Systems?

UFP Technologies (NASDAQ:UFPT) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

In the previous week, UFP Technologies had 7 more articles in the media than Merit Medical Systems. MarketBeat recorded 18 mentions for UFP Technologies and 11 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.84 beat UFP Technologies' score of 0.74 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	6 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	4 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Merit Medical Systems has higher revenue and earnings than UFP Technologies. UFP Technologies is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.90	$68.31M	$9.81	30.93
Merit Medical Systems	$1.61B	3.24	$128.49M	$2.66	32.79

UFP Technologies has a net margin of 11.78% compared to Merit Medical Systems' net margin of 9.94%. UFP Technologies' return on equity of 18.46% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.78%	18.46%	12.41%
Merit Medical Systems	9.94%	14.12%	8.37%

UFP Technologies has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market.

87.3% of UFP Technologies shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 4.6% of UFP Technologies shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Merit Medical Systems has a consensus target price of $105.55, indicating a potential upside of 21.00%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Merit Medical Systems	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.62

Summary

UFP Technologies and Merit Medical Systems tied by winning 8 of the 16 factors compared between the two stocks.

How does UFP Technologies compare to ICU Medical?

UFP Technologies (NASDAQ:UFPT) and ICU Medical (NASDAQ:ICUI) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk.

In the previous week, ICU Medical had 2 more articles in the media than UFP Technologies. MarketBeat recorded 20 mentions for ICU Medical and 18 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 0.74 beat ICU Medical's score of 0.62 indicating that UFP Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	6 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ICU Medical	4 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

UFP Technologies has higher earnings, but lower revenue than ICU Medical. UFP Technologies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.90	$68.31M	$9.81	30.93
ICU Medical	$2.23B	1.93	$730K	$2.39	72.01

UFP Technologies has a net margin of 11.78% compared to ICU Medical's net margin of 2.76%. UFP Technologies' return on equity of 18.46% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.78%	18.46%	12.41%
ICU Medical	2.76%	8.46%	4.49%

UFP Technologies has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market. Comparatively, ICU Medical has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

87.3% of UFP Technologies shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 4.6% of UFP Technologies shares are held by company insiders. Comparatively, 2.1% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

ICU Medical has a consensus price target of $195.20, indicating a potential upside of 13.42%. Given ICU Medical's stronger consensus rating and higher possible upside, analysts plainly believe ICU Medical is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89

Summary

UFP Technologies beats ICU Medical on 9 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to Envista?

UFP Technologies (NASDAQ:UFPT) and Envista (NYSE:NVST) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment.

UFP Technologies has a beta of 1.09, indicating that its stock price is 9% more volatile than the broader market. Comparatively, Envista has a beta of 0.94, indicating that its stock price is 6% less volatile than the broader market.

87.3% of UFP Technologies shares are owned by institutional investors. 4.6% of UFP Technologies shares are owned by company insiders. Comparatively, 1.0% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Envista had 1 more articles in the media than UFP Technologies. MarketBeat recorded 19 mentions for Envista and 18 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 0.74 beat Envista's score of 0.56 indicating that UFP Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	6 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	3 Very Positive mention(s)	5 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

UFP Technologies has higher earnings, but lower revenue than Envista. Envista is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.90	$68.31M	$9.81	30.93
Envista	$2.72B	1.49	$47M	$3.87	6.51

Envista has a consensus target price of $29.00, indicating a potential upside of 15.09%. Given Envista's stronger consensus rating and higher probable upside, analysts plainly believe Envista is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envista	0 Sell rating(s)	11 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.35

Envista has a net margin of 22.01% compared to UFP Technologies' net margin of 11.78%. UFP Technologies' return on equity of 18.46% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.78%	18.46%	12.41%
Envista	22.01%	8.26%	4.54%

Summary

UFP Technologies beats Envista on 10 of the 16 factors compared between the two stocks.

How does UFP Technologies compare to Neogen?

UFP Technologies (NASDAQ:UFPT) and Neogen (NASDAQ:NEOG) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Neogen has a consensus target price of $12.67, suggesting a potential upside of 7.71%. Given Neogen's stronger consensus rating and higher possible upside, analysts clearly believe Neogen is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Neogen	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

UFP Technologies has higher earnings, but lower revenue than Neogen. Neogen is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.90	$68.31M	$9.81	30.93
Neogen	$870.40M	2.95	-$7.90M	-$0.25	N/A

UFP Technologies has a net margin of 11.78% compared to Neogen's net margin of -6.35%. UFP Technologies' return on equity of 18.46% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.78%	18.46%	12.41%
Neogen	-6.35%	3.29%	2.06%

UFP Technologies has a beta of 1.09, indicating that its stock price is 9% more volatile than the broader market. Comparatively, Neogen has a beta of 1.86, indicating that its stock price is 86% more volatile than the broader market.

87.3% of UFP Technologies shares are held by institutional investors. Comparatively, 96.7% of Neogen shares are held by institutional investors. 4.6% of UFP Technologies shares are held by insiders. Comparatively, 0.5% of Neogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, UFP Technologies had 7 more articles in the media than Neogen. MarketBeat recorded 18 mentions for UFP Technologies and 11 mentions for Neogen. UFP Technologies' average media sentiment score of 0.74 beat Neogen's score of 0.53 indicating that UFP Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	6 Very Positive mention(s)	3 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Neogen	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

UFP Technologies beats Neogen on 10 of the 16 factors compared between the two stocks.

Get UFP Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UFPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UFPT vs. The Competition

Export

Metric	UFP Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.35B	$6.16B	$7.76B	$11.80B
Dividend Yield	N/A	1.68%	2.47%	4.59%
P/E Ratio	30.93	37.83	34.49	30.58
Price / Sales	3.90	5.37	8.23	5.55
Price / Cash	24.56	23.17	21.82	22.30
Price / Book	4.84	4.69	4.53	3.82
Net Income	$68.31M	$147.03M	$3.51B	$382.47M
7 Day Performance	6.67%	-0.25%	-1.01%	-2.27%
1 Month Performance	5.90%	-1.31%	-4.45%	-7.57%
1 Year Performance	34.21%	3.29%	2.63%	-6.75%

UFP Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UFPT UFP Technologies	2.0321 of 5 stars	$303.47 +1.2%	N/A	+34.2%	$2.35B	$602.80M	30.93	5,349	Earnings Report Analyst Forecast
BLCO Bausch + Lomb	4.2122 of 5 stars	$20.08 +0.4%	$20.83 +3.8%	+28.9%	$7.15B	$5.42B	N/A	13,000	Analyst Revision
MMSI Merit Medical Systems	3.5261 of 5 stars	$84.31 -2.2%	$105.55 +25.2%	-0.4%	$5.51B	$1.52B	31.70	7,500	News Coverage
ICUI ICU Medical	2.3417 of 5 stars	$162.38 -0.9%	$192.80 +18.7%	+22.8%	$4.16B	$2.23B	137.61	13,000	Trending News Earnings Report Analyst Forecast
NVST Envista	3.7255 of 5 stars	$24.72 +5.1%	$28.86 +16.7%	+29.4%	$3.85B	$2.72B	42.62	12,000	Trending News Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UFPT) was last updated on 11/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

How does UFP Technologies compare to Bausch + Lomb?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Summary

How does UFP Technologies compare to ICU Medical?

Summary

How does UFP Technologies compare to Envista?

Summary

How does UFP Technologies compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

How does UFP Technologies compare to Bausch + Lomb?

Does the media favor UFPT or BLCO?

Which has better valuation & earnings, UFPT or BLCO?

Is UFPT or BLCO more profitable?

Which has more risk and volatility, UFPT or BLCO?

Do institutionals and insiders believe in UFPT or BLCO?

Do analysts prefer UFPT or BLCO?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Does the media favor UFPT or MMSI?

Which has better earnings & valuation, UFPT or MMSI?

Is UFPT or MMSI more profitable?

Which has more risk and volatility, UFPT or MMSI?

Do institutionals & insiders believe in UFPT or MMSI?

Do analysts recommend UFPT or MMSI?

Summary

How does UFP Technologies compare to ICU Medical?

Does the media refer more to UFPT or ICUI?

Which has preferable valuation and earnings, UFPT or ICUI?

Is UFPT or ICUI more profitable?

Which has more volatility & risk, UFPT or ICUI?

Do insiders & institutionals believe in UFPT or ICUI?

Do analysts prefer UFPT or ICUI?

Summary

How does UFP Technologies compare to Envista?

Which has more risk & volatility, UFPT or NVST?

Do insiders and institutionals believe in UFPT or NVST?

Does the media favor UFPT or NVST?

Which has stronger earnings and valuation, UFPT or NVST?

Do analysts recommend UFPT or NVST?

Is UFPT or NVST more profitable?

Summary

How does UFP Technologies compare to Neogen?

Do analysts recommend UFPT or NEOG?

Which has stronger valuation & earnings, UFPT or NEOG?

Is UFPT or NEOG more profitable?

Which has more volatility & risk, UFPT or NEOG?

Do institutionals & insiders hold more shares of UFPT or NEOG?

Does the media favor UFPT or NEOG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools